Arrigo, Alessandro http://orcid.org/0000-0003-4715-8414
Battaglia Parodi, Maurizio
Aragona, Emanuela
Pina, Adelaide
Calcagno, Francesca
Bandello, Francesco
MacLaren, Robert E. http://orcid.org/0000-0002-3096-4682
Article History
Received: 20 September 2021
Revised: 6 January 2022
Accepted: 19 January 2022
First Online: 28 January 2022
Competing interests
: FB consultant for Alcon (Fort Worth, TX, USA), Alimera Sciences (Alpharetta, GA, USA), Allergan Inc (Irvine, CA, USA), Farmila-Thea (Clermont-Ferrand, France), Bayer Shering-Pharma (Berlin, Germany), Bausch And Lomb (Rochester, NY, USA), Genentech (San Francisco, CA, USA), Hoffmann-La-Roche (Basel, Switzerland), NovagaliPharma (Évry, France), Novartis (Basel, Switzerland), Sanofi-Aventis (Paris, France), Thrombogenics (Heverlee, Belgium), Zeiss (Dublin, USA). RM is a consultant to Biogen (Boston, USA). All other authors have no disclosures to declare.